Pricing & Contracting USA 2026

Pricing & Contracting USA 2026 is where Medicaid, Commercial & Government Teams collaborate to drive a comprehensive market strategy, uniting Policy, Pricing, Contracting & Reporting Thought-Leaders at one exceptional event. This conference provides insights gained from a vibrant pricing and contracting community, offering an upgraded program packed with cutting-edge topics such as Medicaid, Government Pricing and Policy, Drug Price Transparency, 340B, Chargeback Management and more. Attendees can expect industry landscape updates from stakeholders across the health ecosystem, fostering maximum cross-collaboration between pricing, government affairs, SPTR, and commercial contracting teams. The event features tactical, hands-on workshops, implementation blueprints for competitive advantage, and over 50 expert-led sessions ranging from foundational concepts to advanced strategies. Key new topics for 2026 include Most Favored Nation (MFN) Pricing Implementation, Medicare Part B Drug Negotiations (2028 Launch), 340B Rebate Model from all stakeholder perspectives, State Medicaid Revenue Transparency Sessions, Cell & Gene Therapy Outcomes-Based Contracting, AI-Powered Pricing Scenario Planning, Direct-to-Consumer Pharma Initiatives, Chargeback Data Accuracy Impact on Rebates, and updates on GTN, GPOs, PBMs, PDABs, SPTR, and Government Shutdown Policy Timeline Disruption. The conference brings together hundreds of professionals for compelling discussions, industry benchmarking, and extended networking.